Showing results (1051-1060 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|February 21, 2014
Monensin inhibits canonical Wnt signaling in human colorectal cancer cells and suppresses tumor growth in multiple intestinal neoplasia miceLucie Tumova, Antonio R Pombinho, Martina Vojtechova, et al.
Molecular Cancer Therapeutics|February 21, 2014
Effect of niclosamide on basal-like breast cancersAngelina I Londoño-Joshi, Rebecca C Arend, Laura Aristizabal, et al.
Molecular Cancer Therapeutics|February 21, 2014
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibodySara Traini, Enza Piccolo, Nicola Tinari, et al.
Molecular Cancer Therapeutics|February 21, 2014
Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitorsGreg M Thurber, Thomas Reiner, Katherine S Yang, et al.
Molecular Cancer Therapeutics|May 3, 2014
Targeted BikDD expression kills androgen-dependent and castration-resistant prostate cancer cellsXiaoming Xie, Yanan Kong, Hailin Tang, et al.
Molecular Cancer Therapeutics|May 3, 2014
Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagySamantha C Ruddy, Rosanna Lau, Miguel A Cabrita, et al.
Molecular Cancer Therapeutics|May 3, 2014
MicroRNA-26b represses colon cancer cell proliferation by inhibiting lymphoid enhancer factor 1 expressionZichao Zhang, KyoungHyun Kim, Xiao Li, et al.
Molecular Cancer Therapeutics|May 3, 2014
Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signalingAnamaria Balic, Morten Dræby Sørensen, Sara Maria Trabulo, et al.
Molecular Cancer Therapeutics|April 2, 2014
Differential antitumor activity of aflibercept and bevacizumab in patient-derived xenograft models of colorectal cancerMarielle Chiron, Rebecca G Bagley, Jack Pollard, et al.
Molecular Cancer Therapeutics|April 2, 2014
MCL-1 degradation mediated by JNK activation via MEKK1/TAK1-MKK4 contributes to anticancer activity of new tubulin inhibitor MT189Wei Wang, Ying-Qing Wang, Tao Meng, et al.
Pageof 599